Last reviewed · How we verify
alphatocopherol
alphatocopherol is a Small molecule drug developed by Frederick Schmitt. It is currently in Phase 2 development. Also known as: Vitamin E.
Alphatocopherol is a small molecule with vitamin E activity, classified as a methylated phenol. It has been studied as a potential intervention for Alzheimer's disease in clinical trials, such as the Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) study.
-
Baseline phase 2 → approval rate
+15.3pp
Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2031–2034 | — |
| EMA | EU | 2032–2035 | +0.7 yr |
| MHRA | GB | 2032–2035 | +0.7 yr |
| Health Canada | CA | 2032–2036 | +0.9 yr |
| TGA | AU | 2032–2036 | +1.2 yr |
| PMDA | JP | 2032–2036 | +1.5 yr |
| NMPA | CN | 2033–2037 | +2.3 yr |
| MFDS | KR | 2032–2036 | +1.4 yr |
| CDSCO | IN | 2032–2037 | +1.8 yr |
| ANVISA | BR | 2033–2037 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | alphatocopherol |
|---|---|
| Also known as | Vitamin E |
| Sponsor | Frederick Schmitt |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- alphatocopherol CI brief — competitive landscape report
- alphatocopherol updates RSS · CI watch RSS
- Frederick Schmitt portfolio CI
Frequently asked questions about alphatocopherol
What is alphatocopherol?
Who makes alphatocopherol?
Is alphatocopherol also known as anything else?
What development phase is alphatocopherol in?
Related
- Manufacturer: Frederick Schmitt — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: Vitamin E
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing